Filed: 5/15/2026ACC: 0001013594-26-000616
📋 What this filing means
SEVEN FLEET CAPITAL MANAGEMENT LP filed this quarterly 13F‑HR report disclosing 114 equity positions with a total reported market value of $315.09M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
114
Positions
$315.09M
Total AUM (reported)
19.63M
Total Shares
Allocation by class
COM$251.49M79.8%
COM NEW$40.94M13.0%
SPONSORED ADS$8.89M2.8%
SHS$5.05M1.6%
COM SHS$4.82M1.5%
ADS$1.94M0.6%
ADR$1.46M0.5%
Portfolio Concentration
Top 3$115.78M36.7%
4–10$47.36M15.0%
11–25$65.25M20.7%
Rest$86.71M27.5%
Top 3 weight
36.7%
Top 10 weight
51.8%
Voting Authority Distribution
Total shares with voting rights: 19.63M
Sole
Full voting authority
14.47M
shares
% of voting shares73.7%
Shared
Joint voting authority
5.16M
shares
% of voting shares26.3%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole99
Shared0
Other15
Dominant voting typeSole · 73.7% of voting shares
Institutional Holdings114
Rows:
CG ONCOLOGY INC
OTRShares1.44M
TypeSH
Market value$97.42M
30.92%
Sole
0.00
Shared
1.44M
None
0.00
TANGO THERAPEUTICS INC
SOLEShares502.01K
TypeSH
Market value$10.50M
3.33%
Sole
502.01K
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC
SOLEShares80.79K
TypeSH
Market value$7.86M
2.49%
Sole
80.79K
Shared
0.00
None
0.00
TYRA BIOSCIENCES INC
SOLEShares195.69K
TypeSH
Market value$7.49M
2.38%
Sole
195.69K
Shared
0.00
None
0.00
LIQUIDIA CORPORATION
SOLEShares187.88K
TypeSH
Market value$7.09M
2.25%
Sole
187.88K
Shared
0.00
None
0.00
AGIOS PHARMACEUTICALS INC
SOLEShares209.55K
TypeSH
Market value$7.09M
2.25%
Sole
209.55K
Shared
0.00
None
0.00
CENTURY THERAPEUTICS INC
SOLEShares2.95M
TypeSH
Market value$6.66M
2.11%
Sole
2.95M
Shared
0.00
None
0.00
ENLIVEN THERAPEUTICS INC
SOLEShares164.03K
TypeSH
Market value$6.43M
2.04%
Sole
164.03K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares108.45K
TypeSH
Market value$6.30M
2.00%
Sole
108.45K
Shared
0.00
None
0.00
TANGO THERAPEUTICS INC
OTRShares300.65K
TypeSH
Market value$6.29M
2.00%
Sole
0.00
Shared
300.65K
None
0.00
COGENT BIOSCIENCES INC
SOLEShares149.40K
TypeSH
Market value$5.75M
1.82%
Sole
149.40K
Shared
0.00
None
0.00
AVALO THERAPEUTICS INC
OTRShares360.06K
TypeSH
Market value$5.38M
1.71%
Sole
0.00
Shared
360.06K
None
0.00
MINERVA NEUROSCIENCES INC
OTRShares889.25K
TypeSH
Market value$5.36M
1.70%
Sole
0.00
Shared
889.25K
None
0.00
CG ONCOLOGY INC
SOLEShares75.76K
TypeSH
Market value$5.13M
1.63%
Sole
75.76K
Shared
0.00
None
0.00
PHARVARIS N V
SOLEShares172.73K
TypeSH
Market value$4.88M
1.55%
Sole
172.73K
Shared
0.00
None
0.00
ABIVAX SA
SOLEShares43.05K
TypeSH
Market value$4.79M
1.52%
Sole
43.05K
Shared
0.00
None
0.00
DIANTHUS THERAPEUTICS INC
SOLEShares54.26K
TypeSH
Market value$4.55M
1.45%
Sole
54.26K
Shared
0.00
None
0.00
PHARVARIS N V
OTRShares143.97K
TypeSH
Market value$4.07M
1.29%
Sole
0.00
Shared
143.97K
None
0.00
CYTOKINETICS INC
SOLEShares61.27K
TypeSH
Market value$4.04M
1.28%
Sole
61.27K
Shared
0.00
None
0.00
SOLENO THERAPEUTICS INC
SOLEShares115.77K
TypeSH
Market value$3.88M
1.23%
Sole
115.77K
Shared
0.00
None
0.00
ENLIVEN THERAPEUTICS INC
OTRShares95.25K
TypeSH
Market value$3.73M
1.19%
Sole
0.00
Shared
95.25K
None
0.00
ERASCA INC
SOLEShares222.47K
TypeSH
Market value$3.60M
1.14%
Sole
222.47K
Shared
0.00
None
0.00
ROIVANT SCIENCES LTD
SOLEShares128.17K
TypeSH
Market value$3.55M
1.13%
Sole
128.17K
Shared
0.00
None
0.00
CYTOMX THERAPEUTICS INC.
OTRShares714K
TypeSH
Market value$3.36M
1.07%
Sole
0.00
Shared
714K
None
0.00
AVALO THERAPEUTICS INC
SOLEShares213.82K
TypeSH
Market value$3.19M
1.01%
Sole
213.82K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CG ONCOLOGY INCOTR | COM | 1.44M | SH | $97.42M 30.92% | 0.00 | 1.44M | 0.00 |
TANGO THERAPEUTICS INCSOLE | COM | 502.01K | SH | $10.50M 3.33% | 502.01K | 0.00 | 0.00 |
REVOLUTION MEDICINES INCSOLE | COM | 80.79K | SH | $7.86M 2.49% | 80.79K | 0.00 | 0.00 |
TYRA BIOSCIENCES INCSOLE | COM | 195.69K | SH | $7.49M 2.38% | 195.69K | 0.00 | 0.00 |
LIQUIDIA CORPORATIONSOLE | COM NEW | 187.88K | SH | $7.09M 2.25% | 187.88K | 0.00 | 0.00 |
AGIOS PHARMACEUTICALS INCSOLE | COM | 209.55K | SH | $7.09M 2.25% | 209.55K | 0.00 | 0.00 |
CENTURY THERAPEUTICS INCSOLE | COM | 2.95M | SH | $6.66M 2.11% | 2.95M | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS INCSOLE | COM | 164.03K | SH | $6.43M 2.04% | 164.03K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 108.45K | SH | $6.30M 2.00% | 108.45K | 0.00 | 0.00 |
TANGO THERAPEUTICS INCOTR | COM | 300.65K | SH | $6.29M 2.00% | 0.00 | 300.65K | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 149.40K | SH | $5.75M 1.82% | 149.40K | 0.00 | 0.00 |
AVALO THERAPEUTICS INCOTR | COM NEW | 360.06K | SH | $5.38M 1.71% | 0.00 | 360.06K | 0.00 |
MINERVA NEUROSCIENCES INCOTR | COM NEW | 889.25K | SH | $5.36M 1.70% | 0.00 | 889.25K | 0.00 |
CG ONCOLOGY INCSOLE | COM | 75.76K | SH | $5.13M 1.63% | 75.76K | 0.00 | 0.00 |
PHARVARIS N VSOLE | COM | 172.73K | SH | $4.88M 1.55% | 172.73K | 0.00 | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 43.05K | SH | $4.79M 1.52% | 43.05K | 0.00 | 0.00 |
DIANTHUS THERAPEUTICS INCSOLE | COM | 54.26K | SH | $4.55M 1.45% | 54.26K | 0.00 | 0.00 |
PHARVARIS N VOTR | COM | 143.97K | SH | $4.07M 1.29% | 0.00 | 143.97K | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 61.27K | SH | $4.04M 1.28% | 61.27K | 0.00 | 0.00 |
SOLENO THERAPEUTICS INCSOLE | COM | 115.77K | SH | $3.88M 1.23% | 115.77K | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS INCOTR | COM | 95.25K | SH | $3.73M 1.19% | 0.00 | 95.25K | 0.00 |
ERASCA INCSOLE | COM | 222.47K | SH | $3.60M 1.14% | 222.47K | 0.00 | 0.00 |
ROIVANT SCIENCES LTDSOLE | SHS | 128.17K | SH | $3.55M 1.13% | 128.17K | 0.00 | 0.00 |
CYTOMX THERAPEUTICS INC.OTR | COM | 714K | SH | $3.36M 1.07% | 0.00 | 714K | 0.00 |
AVALO THERAPEUTICS INCSOLE | COM NEW | 213.82K | SH | $3.19M 1.01% | 213.82K | 0.00 | 0.00 |
Page 1 of 5
…